S-1 combined preoperative neoadjuvant Multimodality therapy with Radiation and Irinotecan for locally advanced rectal cancer

Trial Profile

S-1 combined preoperative neoadjuvant Multimodality therapy with Radiation and Irinotecan for locally advanced rectal cancer

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 17 May 2016

At a glance

  • Drugs Gimeracil/oteracil/tegafur (Primary) ; Irinotecan
  • Indications Rectal cancer
  • Focus Therapeutic Use
  • Acronyms SAMRAI2
  • Most Recent Events

    • 06 Jul 2015 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
    • 01 Oct 2013 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan record.
    • 30 Jul 2013 Planned initiation date changed from 1 Aug 2013 to 1 Oct 2013 as reported by University Hospital Medical Information Network - Japan record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top